TABLE 1.
Strain | Sourcea | PCR resultb |
---|---|---|
V. vulnificus | ||
MO6-24/O | Clinical, Calif. | + |
MO6-24/T | MO6-24/O phase variant | + |
MO6-24/31T | MO6-24/O acapsular mutant | + |
CVD752 | MO6-24/O acapsular mutant | + |
CVD737 | MO6-24/O acapsular mutant | + |
E4125/O | Clinical | + |
NJMSA/O | Clinical, N.J. | + |
BO6312/O | Clinical, Md. | + |
52785/O | Clinical, N.Y. | + |
6353/O | Clinical, Md. | + |
1015H | Clinical, La. | + |
EDL174/O | Clinical, Ga. | + |
LC4/O | Clinical | + |
LC4/T | LC4/O phase variant | + |
5C1326/O | Clinical, Md. | + |
85A667/O | Clinical, Calif. | + |
2400112 | Clinical, Fla. | + |
LL728 | Clinical, Fla. | + |
VV1009 | Environmental, Fla. | + |
345/O | Environmental, La. | + |
345/T | 345/O phase variant | + |
UNCC 913 | Environmental, N.C. | + |
UNCC1015 | Environmental, N.C. | + |
MLT 365 | Environmental, Fla. | + |
MLT 367 | Environmental, Fla. | + |
MLT 403 | Environmental, Fla. | + |
409/O | Unknown | + |
80363/O | Unknown | + |
V. cholerae | ||
NRT36S | Clinical, Japan | − |
JVB52 | NRT36S phase variant | − |
A 5 | Environmental | − |
JVB25 | Unknown | − |
2076 | Unknown | − |
YVY 210 | Unknown | − |
YVY 212 | Unknown | − |
V. parahaemolyticus | ||
ATCO 1782 | Clinical, Japan | − |
NY 3547 | Clinical, N.Y. | − |
TX2103 | Clinical, Tex. | − |
NY3483 | Clinical, N.Y. | − |
10290 | Clinical, Wash. | − |
ATCC 43996 | Clinical, England | − |
Salmonella enterica | ||
Cholerasius 10708 | Clinical | − |
Enteridis 13076 | Clinical | − |
L. monocytogenes | ||
ATCC 7644 | Clinical | − |
ATCC 49594 | Clinical | − |
E. coli | ||
O157:H7 | Clinical | − |
JM109 | K-12 | − |
ATCC 25922 | Clinical, Wash. | − |
P. aeruginosa ATCC 15442 | Environmental | − |
Shigella flexneri ATCC 12022 | Clinical | − |
Suppliers of bacterial strains are provided in the text.
Real-time PCR assay results are shown as either positive ΔRn (+) or no observed amplification (−) as described in Materials and Methods.